Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline

Larsson, K; Hjemdahl, P
September 1989
Thorax;Sep1989, Vol. 44 Issue 9, p767
Academic Journal
No abstract available.


Related Articles

  • Confounding by Indication and Channeling over Time: The Risks of β2-Agonists. Blais, Lucie; Ernst, Pierre; Suissa, Samy // American Journal of Epidemiology;1996, Vol. 144 Issue 12, p1161 

    A previously published nested case-control study, the Saskatchewan Asthma Epidemiologic Project (SAEP) spanning 1980–1987, investigated the risk of fatal or near fatal asthma and found different risks for two inhaled β2-agonists, fenoterol and salbutamol. The authors assessed whether...

  • Hypokalaemia in Healthy Volunteers after Single and Multiple Doses of Formoterol or Salbutamol. van den Berg, B.T.J.; Louwerse, R.T.; Luiken, G.J.H.M.; Jonkers, R.E.; van Boxtel, C.J. // Clinical Drug Investigation;1998, Vol. 15 Issue 6, p523 

    A specific β-adrenoceptor-mediated effect, hypokalaemia, was studied in healthy volunteers after single as well as multiple dosages of the long-acting agonist formoterol and the short-acting agent salbutamol. The purpose of the study was to test with simple methodologies if rapidly induced...

  • Intravenous...agonist in severe acute asthma.  // BMJ: British Medical Journal (International Edition);8/13/88, Vol. 297 Issue 6646, p447 

    Examines the effectiveness of salbutamol in treating severe asthma when given intravenously or by inhalation. Comparison between the effectiveness of intravenous salbutamol and nebulized salbutamol; Change in peak expiratory flow rate; Adverse effects of treatment.

  • Protective effect of inhaled salbutamol powder in children assessed by histamine challenge. Pullan, C.R.; Martin, A.J. // British Medical Journal;2/9/1980, Vol. 280 Issue 6211, p364 

    Examines the effect of inhaled salbutamol powder in children. Administration of placebo controlled trial and inhaled salbutamol powder on children; Assessment of the effect through histamine challenge; Requirement for effectiveness of the dosage; Significance of histamine challenge for...

  • From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain. Barrot, Michel; Yalcin, Ipek; Choucair-Jaafar, Nada; Benbouzid, Malika; Freund-Mercier, Marie-José // Recent Patents on CNS Drug Discovery;Nov2009, Vol. 4 Issue 3, p182 

    The market for pain treatment is a major segment of nervous system pathologies. Despite this dynamism, the management of some pain conditions remains a clinical challenge. Neuropathic pain arises as a direct consequence of a lesion or disease affecting the somatosensory system. It is generally a...

  • Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases. Casoni, Daniela; Spadavecchia, Claudia; Adami, Chiara // Acta Veterinaria Scandinavica;2014, Vol. 56 Issue 1, p1 

    Prevention and treatment of intraoperative hypoxemia in horses is difficult and both efficacy and safety of therapeutic maneuvers have to be taken into account. Inhaled salbutamol has been suggested as treatment of hypoxia in horses during general anesthesia, due to safety and ease of the...

  • Dependency upon Salbutamol Inhalers. Edwards, J. Guy; Holgate, S. T. // British Journal of Psychiatry;Jun79, Vol. 134, p624 

    A case of dependency on salbutamol inhalers has been described. This has been discussed in relation to abuse of other drugs by alveolar absorption and other effects of salbutamol. It is not known whether the dependency is due to the salbutamol itself or to the fluorinated hydrocarbons used as...

  • Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children. Jartti, T. T.; Kaila, T. J.; Tahvanainen, K. U. O.; Kuusela, T. A.; Vanto, T. T.; Välimäki, I. A. T. // European Journal of Pediatrics;1997, Vol. 156 Issue 11, p883 

    We studied the effects of therapeutic 2-week inhaled salbutamol treatment on the cardiovascular and respiratory autonomic nervous regulation in eight children with asthma. In this randomized, double-blind, placebo-controlled crossover study our test subjects inhaled 200 μg salbutamol or...

  • Formoterol: An Update of its Pharmacological Properties and Therapeutic Efficacy in the Management of Asthma. Bartow, R.A.; Brogden, R.N. // Drugs;Feb1998, Vol. 55 Issue 2, p303 

    Formoterol, a selective β2-adrenoceptor agonist, produces effective dose-proportional bronchodilation, which persists for up to 12 hours, in patients with reversible obstructive respiratory disease. Bronchodilation is significant within minutes of inhalation, maximal within 2 hours, and at...

  • Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. Rosenborg, J.; Bengtsson, T.; Larsson, P.; Blomgren, A.; Persson, G.; Lö;tvall, J. // European Journal of Clinical Pharmacology;Aug2000, Vol. 56 Issue 5, p363 

    Objectives: To compare the relative systemic dose potency and tolerability of inhaled formoterol and salbutamol and to describe elimination of formoterol, particularly any enantioselectivity. Methods: Twelve healthy subjects, aged 18–28 years, completed three open study days, and eleven...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics